Since the early 1990s, when Roberts and Szabos cytoprotection concept had already been more than one decade old, but still not implemented in therapy, we suggest the stable gastric pentadecapeptide BPC 157 as the most relevant mediator of the cytoprotection concept.
These may complement BPC-157s effects without the potential downsides of pharmaceutical anti-inflammatories during active tissue repair
Many patients explore peptide therapy to support healthy aging, energy levels, recovery, sleep quality, cognitive function, metabolism, skin health, and overall vitality
Starting too high risks side effects and wastes product
And you also shut down 503(b)s, which is half of the compounding industry's ability to make these compounds